Home » » Mankind Pharma gets DRDO nod to manufacture, market COVID drug 2-DG https://ift.tt/eA8V8J

Mankind Pharma gets DRDO nod to manufacture, market COVID drug 2-DG https://ift.tt/eA8V8J

No comments
2-DG was developed by the Defence Research and Development Establishment (DRDE), Gwalior. The clinical trials were conducted by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO, in association with Dr Reddy's Laboratories, Mankind Pharma said in a statement.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3wpWG4o
Share:

No comments:

Post a Comment

Search This Blog
Powered by Blogger.

Labels

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.